Rockefeller Capital Management’s Tenax Therapeutics TENX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2 Hold
1
– – ﹤0.01% 4860
2026
Q2
$15 Sell
1
-2,500
-100% -$31.9K ﹤0.01% 4713
2026
Q1
$40K Buy
2,501
+2,500
+250,000% +$33.8K ﹤0.01% 3393
2025
Q4
$12 Sell
1
-1
-50% -$9 ﹤0.01% 4658
2025
Q3
$15 Buy
+2
New +$12 ﹤0.01% 4411

Other funds holding TENX

Rockefeller Capital Management's TENX Position: Q3 2026 in Review

Rockefeller Capital Management held its Tenax Therapeutics (TENX) position steady in Q3 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #4860.

Rockefeller Capital Management first reported a position in TENX in Q3 2025 and has held it in 5 quarters since. The position peaked at $40K in Q1 2026. 106 funds tracked by Wall St. Rank hold TENX as of Q3 2026.

  • Rockefeller Capital Management held 1 share of Tenax Therapeutics worth $2 as of Q3 2026.
  • Rockefeller Capital Management left its Tenax Therapeutics share count unchanged in Q3 2026.
  • Tenax Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4860 holding.
  • Rockefeller Capital Management first reported a position in Tenax Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • Rockefeller Capital Management's Tenax Therapeutics position peaked at $40K in Q1 2026.
  • 106 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.